A study by S.E. Peters et al titled “Menstrual Abnormalities Strongly Associated with Proximity to COVID-19 Vaccinated Individuals” posted on 7 December 2024 suggests what has been talked about for the past few years: that unvaccinated women experience abnormal menstrual symptoms due to exposure to the vaccinated.
The paper is 27 pages long. The main text is about 2 pages, the remaining are acknowledgements and references.
The study is an analysis of a survey of 91 questions that queried 39 abnormal symptoms, amongst other things. The study sample involved 6,049 women from age 18 years to 85 years. Data was collected from 16 May 2021 to 31 December 2021. No financial incentives were offered for participation.
The participants are classified into two groups:
Indirect exposure – 3,390 (56%) of women were indirectly exposed to the COVID-19 vaccine by proximity to vaccinated individuals.
Direct exposure – 2,659 (44%) of women were directly exposed to the COVID-19 vaccine or by infection.
Most were non-Hispanic white (86.7%) and the mean age was 37.8 ± 0.1 years with 81.2% from the US, 8.1% from Canada, and 10.7% simply classified as “Other”.
Interestingly, the percentage that took Vitamin D, Vitamin C, magnesium and zinc supplements are significantly higher but still comparable in the indirect exposure group. For example, 26.1% of the indirect exposure group compared to 22.8% of the direct exposure group took Vitamin D.
Generally, a higher percentage of the direct exposure group experienced symptoms on the same day but a lower percentage within 3 days or more compared to the indirect exposure group, “possibly suggesting a more immediate reaction for those exposed directly to the COVID-19 vaccine injection and/or to infection by SARS-CoV-2”.
One of our most striking findings was that 92.3% of the indirect exposure sample said that their abnormal or irregular first-time symptoms started after January 2021, including the 46-54 year-olds at 94%.
That is interesting considering that there were high infection rates reported in 2020 but these abnormal symptoms did not begin until January 2021 which was about the time when the vaccine became widely available.
It was hypothesized that the more exposure to the vaccinated, the higher the risk of experiencing abnormal symptoms. As such, one might assume those who live with a vaccinated person would have the highest risk ratios (RR) than other groups. But it is not that simple.
[T]he significant and highest relative risk across several symptoms, including heavier bleeding (34%), early period onset (28%), and extended bleeding (26%), was for those who were exposed to the vaccinated daily and within 6 feet, but outside of the household. One possible explanation for this result is that daily exposure to a larger public group of vaccinated individuals could increase the concentration and duration of exposure to vaccine components being transmitted in the environment.
Table 4 reproduced below shows that compared to unvaccinated women whose exposure is “Seldom/Sometimes/Daily outside 6 feet”, it is those whose exposure is “Daily within 6 feet outside household” that are the worse.
However one looks at it, it is clear enough that unvaccinated women experience abnormal symptoms when exposed to the vaccinated.
This observational study found that women with no direct COVID-19 vaccine or SARS-CoV-2 exposure seemed to be having menstrual abnormalities similar to those reported by the vaccinated population. Our findings suggest possible indirect transmission of ingredients or products of the COVID-19 vaccines, presumably through shedding, from people who received one or more of the COVID-19 injections.
Be sure to subscribe to our mailing list so you get each new Opinyun that comes out!
Comments